1.Effect of Yinchenhao decoction on renal oxidative stress injury in rats with obstructive jaundice and its mechanism of action based on the nuclear factor erythroid 2-related factor 2 signaling pathway
Junjian LIU ; Shuai CHEN ; Hongxia YUAN ; Yan XU ; Xibo ZHANG ; Zhonglian LI
Journal of Clinical Hepatology 2023;39(5):1126-1133
		                        		
		                        			
		                        			 Objective To investigate the effect of Yinchenhao decoction on renal oxidative stress injury in rats with obstructive jaundice and its association with the regulation of the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear translocation. Methods A total of 32 male Sprague-Dawley rats were randomly divided into sham-operation group (S group), model group (O group), low-dose Yinchenhao decoction group (LY group), and high-dose Yinchenhao decoction group (HY group), with 8 rats in each group. For the rats in the S group, the upper common bile duct was isolated without ligation, and for those in the other groups, double ligation of the middle and upper 1/3 of the common bile duct was performed to establish a model of obstructive jaundice. After 7 days, the rats in the LY group and the HY group were given Yinchenhao decoction by gavage at a dose of 6.3 and 18.9 mL/kg, respectively, while those in the S and O groups were given an equal volume of distilled water by gavage every day for 7 consecutive days, and the rats were treated on day 14. ELISA was used to measure the serum levels of total bilirubin (TBil), direct bilirubin (DBil), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), blood urea nitrogen (BUN), and creatinine (Cr); spectrophotometry was used to measure the activity of the oxidative stress factors superoxide dismutase (SOD) and malondialdehyde (MDA) in renal tissue; quantitative real- time PCR and Western blotting were used to measure the mRNA and protein expression levels of Nrf2, Kelch-like ECH-associated protein 1 (Keap1), and NAD(P)H quinone dehydrogenase 1 (NQO1) in renal tissue; immunohistochemistry was used to measure observe the nuclear translocation of Nrf2 protein in renal tissue. A one-way analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t -test was used for further pairwise comparison within groups. Results Compared with the S group, the O group had significant increases in the levels of TBil, DBil, ALT、GGT, BUN, and Cr, a significant reduction in the activity of SOD, and a significant increase in the level of MDA (all P < 0.05). Compared with the O group, the LY group and the HY group had significant reductions in liver and renal function parameters, a significant increase in the activity of SOD, and a significant reduction in the level of MDA (all P < 0.05). Compared with the S group, the O group had significant reductions in the mRNA and protein expression levels of Nrf2 and NQO1 in renal tissue (all P < 0.05), and compared with the O group, the LY group and the HY group had significant increases in the mRNA and protein expression levels of Nrf2 and NQO1 (all P < 0.05), while there was no significant difference in the protein expression level of Keap1 between groups ( P > 0.05). Compared with the S group, the O group had a significant reduction in the positive rate of Nrf2 in cell nucleus in renal tissue ( P < 0.05), and compared with the O group, the LY group and the HY group had a significant increase in the positive rate of Nrf2 in cell nucleus ( P < 0.05). Conclusion Yinchenhao decoction can effectively alleviate renal injury caused by obstructive jaundice, possibly by upregulating the protein expression of Nrf2 in renal tissue and regulating the nuclear translocation of Nrf2 protein, so as to mediate the protein expression of downstream NQO1, regulate oxidative stress response caused by obstructive jaundice, and thereby alleviate renal injury in rats. 
		                        		
		                        		
		                        		
		                        	
2.Role of HBV DNA polymerase in mediating the immune escape of tumor cells in HBV-related hepatocellular carcinoma
Hongxia LI ; Yimeng SUN ; Hongtao ZHANG ; Shuwang HAN ; Delin ZHANG ; Haitao SHANG ; Wu GUO ; Junjian LIU ; Zhonglian LI
Journal of Clinical Hepatology 2023;39(12):2858-2866
		                        		
		                        			
		                        			ObjectiveTo determine whether HBV DNA polymerase is associated with T-cell failure and thus mediates the immune escape of HBV-related hepatocellular carcinoma (HCC) tumor cells, and to investigate the specific molecular mechanisms. MethodsLiver cancer cell lines Huh7 and HepG2 stably transfected with HBV DNA polymerase expression plasmid with Flag (Flag-HBV-P) and intercellular adhesion molecule-1 (ICAM1) were co-cultured with Jurkat cells, and MTT assay, qRT-PCR, and ELISA were used to measure Jurkat cell proliferation, activation (CD69 expression), and secretion of the cytokine IFN-γ. RNA-seq was used to screen for differentially expressed immune-associated molecules between stably transfected cell lines and control cells, and mRNA half-life and protein half-life assays were used to determine the specific levels of the immune-associated molecules that were affected by HBV DNA polymerase. Related websites were used to predict the transcription factors that may bind to the promoter region of this immune-associated molecule, Western blot was used to verify the effect of transcription factors on the immune-associated molecule, and rescue experiment was used to determine whether HBV DNA polymerase affects the expression level of the immune-associated molecule through this transcription factor. The independent-samples t test was used for comparison between two groups. ResultsThe experimental group had significant reductions in Jurkat cell proliferation, activation, and cytokine secretion compared with the control group (all P<0.01). Compared with the control group, the experimental group (Huh7 and HepG2 cell lines) had significant reductions in the mRNA and protein expression levels of ICAM1 (all P<0.01). Website prediction identified the ICAM1 promoter and preliminarily highlighted NFKB1, RELA, and STAT3. Compared with the control group, the experimental group (Huh7 and HepG2 cell lines) had a significant reduction in the protein expression level of p65 (all P<0.01). After p65 overexpression, there was a significant increase in the protein expression level of ICAM1, and after the expression of p65 was reduced, there was a significant reduction in the protein expression level of ICAM1 (all P<0.01). In the rescue experiment, there was no significant difference in the protein expression level of ICAM1 between the control group and the experimental group after p65 overexpression (all P>0.05). After the overexpression of ICAM1, there were no significant differences in the proliferation, activation, and cytokine secretion of Jurkat cells between the control group and the experimental group (Huh7 and HepG2 cell lines) (all P>0.05). ConclusionHBV DNA polymerase downregulates the level of ICAM1 to mediate HCC immune escape by inhibiting the expression of p65 in NF-κB. 
		                        		
		                        		
		                        		
		                        	
3.Comparison of laparoscopic and open surgery in the treatment of Mirizzi syndrome
Ming LI ; Dapeng ZHANG ; Xiaojun SUI ; Junjian LIU ; Ning LI ; Zhenyu WANG
Chinese Journal of Hepatobiliary Surgery 2023;29(12):897-901
		                        		
		                        			
		                        			Objective:To compare the laparoscopic and open surgery in the treatment of Mirizzi syndrome (MS).Methods:The clinical data of 125 patients with MS undergoing surgery in Tianjin Nankai Hospital from May 2013 to April 2020 were retrospectively analyzed, including 59 males and 66 females, aged (57.7±13.6) years old. Patients were divided into the laparoscopic group ( n=84) and open group ( n=41). General data, operation time, intraoperative blood loss, postoperative complications, postoperative and total hospital were compared between the groups. Patients were followed up and screened for biliary stone recurrence or biliary stenosis by phone or Wechat. Results:The postoperative hospital stay [8.00(5.25, 12.00) d vs. 13.00(10.00, 17.50) d, P<0.001] and total hospital stay [15.00 (10.25, 22.75) d vs. 22.00 (16.00, 27.50) d, P<0.001] were shorter in laparoscopic group. The conversion rate of laparoscopic group was 15.5% (13/84). No perioperative death occurred in either group. The incidence of postoperative complications were comparable between the groups [9.5%(8/84) vs. 7.3%(3/41), P>0.05]. In laparoscopic group, 64 patients were followed up [76.2% (64/84)]. During follow-up, there were two deaths, five cases of bile duct stones recurrence and one case of bile duct stenosis. In open group, 37 patients were followed up [90.2% (37/41)]. During follow-up, there were four deaths, four cases of bile duct stones recurrence. All deaths during follow-ups were non-MS-related. Conclusion:Compared to open surgery, laparoscopic surgery could shorten the total/postoperative hospital stay while does not increase the morbidity and mortality, which could be safe and feasible in the treatment of MS.
		                        		
		                        		
		                        		
		                        	
4.Analysis of surgical complications after laparoscopic duodenum-preserving pancreatic head resection for noncancerous lesions
Wei CHAI ; Zhiquan ZHANG ; Bao LEI ; Junjian YUAN ; Yu MENG ; Xiulei ZHAO ; Lei ZHANG ; Ruhai LIU
Chinese Journal of General Surgery 2022;37(6):443-446
		                        		
		                        			
		                        			Objective:To analyze the common complications of laparoscopic duodenum- preserving pancreatic head resection(LDPPHR).Methods:The clinical data of 32 patients undergoing LDPPHR from Jun 2018 to Jun 2021 in Cangzhou Central Hospital were analyzed retrospectively.Results:LDPPHR was successfully performed in all 32 patients without conversion to open surgery. The incidence of postoperative complications was 21.9% (7/32), 3 cases suffering from sever complications (1 case of long-term postoperative pancreatic fistula, 1 case of obstructive jaundice caused by duodenal papilla stenosis, 1 case of postoperative abdominal bleeding) were cured by laparotomy; 4 cases of minor complications were simple pancreatic fistula, which were cured by prolonging dranage.Conclusions:LDPPHR is technically feasible for isolated noncancerous lesions within pancreatic head and uncinate process,the complications were manageable.Its suggested benefits remain to be established by long term follow-up.
		                        		
		                        		
		                        		
		                        	
5.Correction to: Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease.
Jianjun JIA ; Jun XU ; Jun LIU ; Yongjun WANG ; Yanjiang WANG ; Yunpeng CAO ; Qihao GUO ; Qiuming QU ; Cuibai WEI ; Wenshi WEI ; Junjian ZHANG ; Enyan YU
Neuroscience Bulletin 2022;38(3):337-338
		                        		
		                        		
		                        		
		                        	
6.The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy.
Zhenzhen LI ; Zhen GUO ; Rui LAN ; Sidong CAI ; Zhirong LIN ; Jingyan LI ; Junjian WANG ; Zhuoming LI ; Peiqing LIU
Acta Pharmaceutica Sinica B 2021;11(5):1286-1299
		                        		
		                        			
		                        			The bromodomain and extraterminal (BET) family member BRD4 is pivotal in the pathogenesis of cardiac hypertrophy. BRD4 induces hypertrophic gene expression by binding to the acetylated chromatin, facilitating the phosphorylation of RNA polymerases II (Pol II) and leading to transcription elongation. The present study identified a novel post-translational modification of BRD4: poly(ADP-ribosyl)ation (PARylation), that was mediated by poly(ADP-ribose)polymerase-1 (PARP1) in cardiac hypertrophy. BRD4 silencing or BET inhibitors JQ1 and MS417 prevented cardiac hypertrophic responses induced by isoproterenol (ISO), whereas overexpression of BRD4 promoted cardiac hypertrophy, confirming the critical role of BRD4 in pathological cardiac hypertrophy. PARP1 was activated in ISO-induced cardiac hypertrophy and facilitated the development of cardiac hypertrophy. BRD4 was involved in the prohypertrophic effect of PARP1, as implied by the observations that BRD4 inhibition or silencing reversed PARP1-induced hypertrophic responses, and that BRD4 overexpression suppressed the anti-hypertrophic effect of PARP1 inhibitors. Interactions of BRD4 and PARP1 were observed by co-immunoprecipitation and immunofluorescence. PARylation of BRD4 induced by PARP1 was investigated by PARylation assays. In response to hypertrophic stimuli like ISO, PARylation level of BRD4 was elevated, along with enhanced interactions between BRD4 and PARP1. By investigating the PARylation of truncation mutants of BRD4, the C-terminal domain (CTD) was identified as the PARylation modification sites of BRD4. PARylation of BRD4 facilitated its binding to the transcription start sites (TSS) of hypertrophic genes, resulting in enhanced phosphorylation of RNA Pol II and transcription activation of hypertrophic genes. The present findings suggest that strategies targeting inhibition of PARP1-BRD4 might have therapeutic potential for pathological cardiac hypertrophy.
		                        		
		                        		
		                        		
		                        	
7.Simultaneous Determination of Four Related Substances in Olmesartan Medoxomil Hydrochlorothiazide Tablets by HPLC-Principal Component Self-Control with Correct Factor
Haoxian LI ; Huaqing LIN ; Junjian LI ; Yuanjian WANG ; Rong LIU ; Chuqin YU
China Pharmacy 2020;31(7):825-830
		                        		
		                        			
		                        			OBJECTIVE: To establish the method for simultaneous determination of four known related substances (olmesartan,olmesartan ester dimer ,olmesartan ester alkene ,benzothiadiazine impurity ,called impurity A ,B,C,D for short )in Olmesartan medoxomil hydrochlorothiazide tablets. METHODS :HPLC-principal component self-control with correction factor were adopted. The determination was performed on YMC-Triart C 8 column with mobile phase A consisted of acetonitrile- 0.015 mol/L potassium dihydrogen phosphate solution (pH adjusted to 2.8 with phosphoric acid )(70 ∶ 30,V/V),mobile phase B consisted of acetonitrile-0.015 mol/L potassium dihydrogen phosphate solution (pH adjusted to 2.8 with phosphoric acid )(15 ∶ 85,V/V)at the flow rate of 0.8 mL/min(gradient elution ). The detection wavelength was set at 265 nm,and column temperature was 25 ℃. The temperature of injector was 4 ℃;the injection volume was 10 μL. RESULTS:The correction factors of impurity A ,B,C,D were 1.42,1.17,0.89,0.92,respectively. The linear range of olmesartan medoxomil ,hydrochlorothiazide and impurity A ,B,C,D were 0.252 7-7.580 0,1.152 1-4.562 9,0.244 0-18.299 0,0.244 7-3.670 8,0.265 2-3.978 3 and 0.149 9-4.497 3 μg/mL(r≥ 0.999 7),respectively. The limits of detection were 0.084 2,0.050 7,0.081 3,0.081 6,0.088 4,0.050 0 μg/mL,respectively. The quantitative limits were 0.252 7,0.152 1,0.244 0,0.244 7,0.265 2 and 0.149 9 μg/mL,respectively. The results of intermediate precision ,stability(24 h)and repeatability tests all met the relevant requirements. The average recovery rates were 104.00%-108.04%,102.00%-104.94%,100.99%-106.89%,92.00%-95.18%,102.00%-105.06%,103.90%-107.00%(n=3), respectively. The contents of impurity A ,B and D in 3 batches of Olmesartan medoxomil hydrochlorothiazide tablets were 0.90% -1.00% ,0-0.11% ,0.16% -0.24% ,respectively. The impurity C and other impurities were not detected. There is no significant difference between the results measured by the established method and by the external standard method. CONCLUSIONS:The method has been proved to be highly sensitive and reproducible. It can be used to simultaneously determine four known substances in Olmesartan medoxomil hydrochlorothiazide tablets.
		                        		
		                        		
		                        		
		                        	
8.Targeting castration-resistant prostate cancer with a novel ROR
Jianwei ZHENG ; Junfeng WANG ; Qian WANG ; Hongye ZOU ; Hong WANG ; Zhenhua ZHANG ; Jianghe CHEN ; Qianqian WANG ; Panxia WANG ; Yueshan ZHAO ; Jing LU ; Xiaolei ZHANG ; Songtao XIANG ; Haibin WANG ; Jinping LEI ; Hong-Wu CHEN ; Peiqing LIU ; Yonghong LIU ; Fanghai HAN ; Junjian WANG
Acta Pharmaceutica Sinica B 2020;10(12):2313-2322
		                        		
		                        			
		                        			Prostate cancer (PCa) patients who progress to metastatic castration-resistant PCa (mCRPC) mostly have poor outcomes due to the lack of effective therapies. Our recent study established the orphan nuclear receptor ROR
		                        		
		                        		
		                        		
		                        	
9.Application of situational simulation combined with video feedback in cardiopulmonary and abdominal probation of diagnostics
Wentao LI ; Chuyuan HU ; Yu LI ; Lan KE ; Guangnan LIU ; Xiaoyu TAN ; Houwen ZHENG ; Junjian CHEN
Chinese Journal of Medical Education Research 2020;19(7):840-843
		                        		
		                        			
		                        			Objective:To investigate the effect of situational simulation combined with video feedback in cardiopulmonary and abdominal clinical probation of diagnostics.Methods:Two hundred and twenty-four clinical undergraduates from the second affiliated hospital of Guangxi Medical University were randomized into the experimental group ( n=112) and the control group ( n=112). The experimental group applied situational simulation combined with video feedback methods in the cardiopulmonary and abdominal clinical probation. In other words, according to the assignment of diseases, two students played the role of "physician and patient" and conducted corresponding consultation and physical examination, in which the positive and negative video feedback were integrated to standardize students' physical examination skills. The control group adopted conventional teaching method. The teaching effect of the two groups was evaluated through unified and standardized scores of theoretical tests, cases analysis, and clinical skills operation, and the experimental group was conducted anonymous questionnaires to 112 students. SPSS 22.0 was used to perform the t test. Results:The evaluation results show that the average scores of theoretical tests (90.12±0.94), cases analysis (9.30±0.10) and physical examination (93.50±0.72) in the experimental group are higher than those of the control group, (83.20±1.66), (8.10±0.11), (85.00±1.75), respectively, with statistical significance ( P<0.05). All 112 questionnaires were collected, with an effective rate of 100%. The percentage of "yes" respondents is as follows, 91.1% of "Enhancing the mastery and application of knowledge"; 97.3% of "Cultivating clinical thinking"; 87.5% of "Improving doctor-patient communication skills"; however, there are 93.8% students believe that this new teaching approach takes more time to prepare before class, consequently, their initiative and enthusiasm of study and learning interest have slid into decline, with percentage of 80.4% and 83.0%, respectively. Conclusion:The teaching method of situational simulation and video feedback in cardiopulmonary and abdominal clinical probation of diagnostics is beneficial to enhance students' understanding and mastery of theoretical knowledge, standardize physical examinations, cultivate clinical thinking ability and improve the doctor-patient communication skills. However, it takes a lot of time for students to prepare before class. If they fail to make reasonable arrangements, the teaching effect will be half the effort and students' initiative and enthusiasm of learning will be reduced.
		                        		
		                        		
		                        		
		                        	
10.Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation.
Jing LU ; Jingyan LI ; Yuehuai HU ; Zhen GUO ; Duanping SUN ; Panxia WANG ; Kaiteng GUO ; Dayue Darrel DUAN ; Si GAO ; Jianmin JIANG ; Junjian WANG ; Peiqing LIU
Acta Pharmaceutica Sinica B 2019;9(4):782-793
		                        		
		                        			
		                        			The clinical application of doxorubicin (DOX) in cancer chemotherapy is limited by its life-threatening cardiotoxic effects. Chrysophanol (CHR), an anthraquinone compound isolated from the rhizome of L., is considered to play a broad role in a variety of biological processes. However, the effects of CHR׳s cardioprotection in DOX-induced cardiomyopathy is poorly understood. In this study, we found that the cardiac apoptosis, mitochondrial injury and cellular PARylation levels were significantly increased in H9C2 cells treated by Dox, while these effects were suppressed by CHR. Similar results were observed when PARP1 activity was suppressed by its inhibitors 3-aminobenzamide (3AB) and ABT888. Ectopic expression of PARP1 effectively blocked this CHR׳s cardioprotection against DOX-induced cardiomyocyte injury in H9C2 cells. Furthermore, pre-administration with both CHR and 3AB relieved DOX-induced cardiac apoptosis, mitochondrial impairment and heart dysfunction in Sprague-Dawley rat model. These results revealed that CHR protects against DOX-induced cardiotoxicity by suppressing cellular PARylation and provided critical evidence that PARylation may be a novel target for DOX-induced cardiomyopathy.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail